Clinical Trial Update: Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

View source ↗

Summary

Expanded access to omaveloxolone for melanoma for patients previously enrolled in trial 408-C-1401 is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Omaveloxolone (omaveloxolone)

Snippet

Sponsor: Biogen | Conditions: Melanoma | Status: NO_LONGER_AVAILABLE